Skip to main content
Skip to list of reports Filters

Date Range

Reports

Search reports, investigative results, and agency plansShowing 1 - 10 of 49 results
Special Inspector General for Pandemic Recovery

Independent Review of Executive Compensation: Yellow Corporation

The objective of this audit is to determine whether Yellow, and its affiliates, complied with executive compensation limits under Section 12.05 of its Loan and Guarantee Agreement with the U.S. Department of the Treasury. 

Special Inspector General for Pandemic Recovery

Compilation of Lessons Learned Report

The objective of the report is to compile SIGPR's audit products as well as lessons learned related to SIGPR's budget, jurisdiction, and hiring authority.

Special Inspector General for Pandemic Recovery

Audit of Risk Factor Mitigation in MSLP Loans

The objective of this review is to develop other MSLP audit ideas derived from our data analytics platform and risk assessment. 

Special Inspector General for Pandemic Recovery

Independent Review of Direct Loan Recipient: Map Large Inc.

The objective of the audit is to determine if Map Large follows the terms and conditions of its direct loan agreement. 

Special Inspector General for Pandemic Recovery

Audit of the Effects the MSLP’s Loan Losses Have on Treasury’s Investment

The Federal Reserve Bank of Boston manages the Main Street Lending Program (MSLP) through a Special Purpose Vehicle, which is backed by a $16.6 billion equity investment by Treasury. SIGPR will issue cyclical interim reports to Treasury on the information gathered from the various banks that participate in the MSLP.

Pandemic Response Accountability Committee

Personnel Shortages for Federal Health Care Programs During the COVID-19 Pandemic

Personnel supporting Federal health care programs are a resource critical to the Federal COVID-19 pandemic response efforts. Health care facilities must be prepared for potential personnel shortages and must have plans and processes in place to mitigate these shortages to combat the COVID-19 pandemic and future pandemics. The PRAC will coordinate a review of four Federal health care programs to determine whether these programs, or the providers they reimburse, experienced shortages in health care personnel during the pandemic, the impact of those health care personnel shortages, and strategies used by the Departments to reduce shortages of health care personnel for future pandemics.

Pandemic Response Accountability Committee

COVID-19 Pandemic Impact - Select Case Studies

Federal agencies were allocated more than $5 trillion in pandemic response funding to be disbursed to the public and to state and local governments, where a state or local government could have received pandemic response funds from multiple federal programs to improve the overall pandemic response in their communities. Access to information about the total amount of funds received, the purpose of those funds, and the progress made toward achieving the program goals and objectives is not always centralized and can be difficult for the public to track down or may not even be available to the public. The PRAC will conduct impact case studies at 6 different locations and seek to identify the federal pandemic response funds provided to the 6 locations and the purpose of those funds, and to determine if the federal program spending aligned with the intended goals and objectives. The 6 locations identified for this project include: Springfield, Massachusetts; Coeur d’Alene, Idaho; Marion County, Georgia; Sheridan County, Nebraska; White Earth Indian Nation, Minnesota; and Jicarilla Apache Nation, New Mexico.

Special Inspector General for Pandemic Recovery

Audit of the Main Street Lending Program

The Office of the Special Inspector General for Pandemic Recovery is evaluating funds that were allocated to the Federal Reserve System’s Main Street Lending Program (MSLP), which had 319 lenders and 1,830 borrowers participating in loans totaling more than $17 billion. The objectives of the audit are to 1) assess the process used by banks to issue loans under the MSLP program; 2) evaluate the process used by the Federal Reserve’s Special Purpose Vehicle to purchase the loans;  3) determine vulnerabilities based on a risk-based analysis; and 4) identify specific areas that warrant further audit work.
 

Department of Health & Human Services OIG

Audit of Health Resources and Services Administration's COVID-19 Supplemental Grant Funding for Health Centers

The Health Resources and Services Administration (HRSA) awarded nearly $2 billion in supplemental grant funding to 1,387 health centers nationwide in fiscal year (FY) 2020 to respond to the COVID-19 public health emergency. The funding was intended to support the health centers' activities related to the detection, prevention, diagnosis, and treatment of COVID-19, including maintaining or increasing health center capacity and staffing levels during the pandemic, and expanding COVID-19 testing. The performance period for each of these one-time supplemental grant awards, which HRSA began awarding in March 2020, is 12 months. Health centers were permitted to charge to their awards pre-award costs in order to support expenses related to the COVID-19 public health emergency dating back to January 20, 2020. We will determine whether health centers used their HRSA COVID-19 supplemental grant funding in accordance with Federal requirements and grant terms.

Department of Health & Human Services OIG

Yearend Review of Opioid Use in Medicare Part D in 2020

Identifying patients who are at-risk of overdose or abuse is key to addressing this crisis. The COVID-19 pandemic has made this need even more pressing. The National Institutes of Health recently warned that individuals with opioiduse disorder could be particularly hard hit by COVID-19, which is a respiratory virus that attacks the lungs. Respiratory disease is known to increase mortality risks among people taking opioids. This data brief would provide information on opioid utilization among beneficiaries enrolled in Medicare Part D in 2020.